|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.840
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.839
|
Human |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.805
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.750
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.736
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.685
|
Human |
|
|
circulatory system development
|
GO:0072359 |
262 |
0.653
|
|
|
|
forebrain regionalization
|
GO:0021871 |
3 |
0.630
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.615
|
Human |
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.581
|
Human |
|
|
skeletal system development
|
GO:0001501 |
79 |
0.568
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.564
|
Human |
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
0.562
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.519
|
|
|
|
fibroblast growth factor receptor signaling pathway involved in mammary gland specification
|
GO:0060595 |
1 |
0.495
|
Human |
|
|
epithelium development
|
GO:0060429 |
227 |
0.480
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.477
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.462
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.461
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.450
|
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.434
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.432
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.429
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.389
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.385
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.382
|
Human |
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.368
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.365
|
Human |
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.362
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.352
|
|
|
|
system process
|
GO:0003008 |
349 |
0.351
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.351
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.349
|
Human |
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.348
|
|
|
|
positive regulation of tooth mineralization
|
GO:0070172 |
2 |
0.344
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.341
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.341
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.340
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.331
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.321
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.320
|
|
|
|
mesonephric duct development
|
GO:0072177 |
3 |
0.315
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.307
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.300
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.297
|
Human |
|
|
canonical wnt signaling pathway involved in osteoblast differentiation
|
GO:0044339 |
2 |
0.282
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.280
|
Human |
|
|
immune system development
|
GO:0002520 |
195 |
0.279
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.275
|
|
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
0.275
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.272
|
Human |
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.272
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.266
|
Human |
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.260
|
|
|
|
positive regulation of glucocorticoid biosynthetic process
|
GO:0031948 |
1 |
0.259
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
2 |
0.258
|
|
|
|
dermatome development
|
GO:0061054 |
3 |
0.252
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.246
|
|
|
|
head development
|
GO:0060322 |
108 |
0.245
|
Human |
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.245
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.241
|
Human |
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.237
|
|
|
|
regulation of dermatome development
|
GO:0061183 |
3 |
0.235
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
1 |
0.232
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.231
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.228
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.223
|
|
|
|
positive regulation of odontogenesis
|
GO:0042482 |
3 |
0.217
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.217
|
Human |
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.214
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.212
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
3 |
0.212
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.210
|
Human |
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.208
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.207
|
Human |
|
|
metencephalon development
|
GO:0022037 |
2 |
0.207
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.205
|
|
|
|
negative regulation of testicular blood vessel morphogenesis
|
GO:0061369 |
1 |
0.204
|
|
|
|
canonical wnt signaling pathway involved in mesenchymal stem cell differentiation
|
GO:0044338 |
2 |
0.200
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.198
|
Human |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.197
|
Human |
|
|
cerebellum development
|
GO:0021549 |
2 |
0.197
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.195
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
7 |
0.192
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.192
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.190
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.190
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.189
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.188
|
Human |
|
|
positive regulation of epithelial cell proliferation involved in wound healing
|
GO:0060054 |
3 |
0.187
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.183
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.183
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.182
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.181
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.180
|
Human |
|
|
kidney development
|
GO:0001822 |
53 |
0.177
|
Human |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.176
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.173
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.173
|
Human |
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.172
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.169
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.168
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.167
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.167
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.165
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.165
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.163
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.163
|
Human |
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.163
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.163
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.161
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.161
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.161
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.160
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.158
|
Human |
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.155
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.154
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.153
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.152
|
|
|
|
negative regulation of male gonad development
|
GO:2000019 |
1 |
0.147
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.145
|
Human |
|
|
hormone transport
|
GO:0009914 |
68 |
0.144
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.144
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.142
|
Human |
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.142
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.141
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.138
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.138
|
|
|
|
limb bud formation
|
GO:0060174 |
1 |
0.138
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.138
|
Human |
|
|
ureteric bud development
|
GO:0001657 |
13 |
0.137
|
Human |
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.137
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.136
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.135
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.134
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.134
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.133
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.131
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.130
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.129
|
Human |
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.129
|
Human |
|
|
blood vessel development
|
GO:0001568 |
172 |
0.128
|
Human |
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.126
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.126
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.126
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.125
|
Human |
|
|
taxis
|
GO:0042330 |
157 |
0.123
|
Human |
|
|
positive regulation of aldosterone metabolic process
|
GO:0032346 |
2 |
0.123
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.123
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.120
|
Human |
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.119
|
Human |
|
|
ureteric bud morphogenesis
|
GO:0060675 |
10 |
0.118
|
Human |
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.118
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
13 |
0.117
|
Human |
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.116
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.116
|
Human |
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.115
|
Human |
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.115
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.115
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.113
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.112
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.111
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.111
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.110
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.109
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.108
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.108
|
Human |
|
|
hormone secretion
|
GO:0046879 |
65 |
0.108
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.106
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.106
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.104
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.104
|
Human |
|
|
positive regulation of cortisol biosynthetic process
|
GO:2000066 |
1 |
0.103
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.102
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.101
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
15 |
0.101
|
Human |
|
|
cell aggregation
|
GO:0098743 |
1 |
0.101
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.101
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.100
|
Human |
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.099
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
1 |
0.099
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.098
|
Human |
|
|
mammary gland formation
|
GO:0060592 |
1 |
0.097
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.096
|
Human |
|
|
cell fate determination
|
GO:0001709 |
3 |
0.095
|
|
|
|
positive regulation of glucocorticoid metabolic process
|
GO:0031945 |
1 |
0.094
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.094
|
Human |
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.094
|
|
|
|
positive regulation of aldosterone biosynthetic process
|
GO:0032349 |
2 |
0.093
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.093
|
Human |
|
|
renal tubule development
|
GO:0061326 |
19 |
0.092
|
Human |
|
|
amide transport
|
GO:0042886 |
76 |
0.092
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.091
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.090
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.090
|
Human |
|
|
cloacal septation
|
GO:0060197 |
1 |
0.090
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.089
|
Human |
|
|
mapk cascade
|
GO:0000165 |
288 |
0.089
|
Human |
|
|
behavior
|
GO:0007610 |
112 |
0.088
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.088
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.088
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.088
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.087
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.087
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.086
|
Human |
|
|
mesonephric epithelium development
|
GO:0072163 |
14 |
0.086
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.086
|
Human |
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.086
|
Human |
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
4 |
0.085
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.085
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.084
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.084
|
Human |
|
|
neuroendocrine cell differentiation
|
GO:0061101 |
2 |
0.084
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.083
|
Human |
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.083
|
|
|
|
right ventricular cardiac muscle tissue morphogenesis
|
GO:0003221 |
2 |
0.083
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.083
|
Human |
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.083
|
Human |
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.082
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.082
|
|
|
|
canonical wnt signaling pathway involved in negative regulation of apoptotic process
|
GO:0044336 |
2 |
0.082
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.082
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.082
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.081
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.080
|
Human |
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.080
|
Human |
|
|
heart field specification
|
GO:0003128 |
2 |
0.077
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.076
|
Human |
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.076
|
Human |
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.076
|
Human |
|
|
embryo development
|
GO:0009790 |
123 |
0.076
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.075
|
Human |
|
|
wnt signaling pathway involved in wound healing spreading of epidermal cells
|
GO:0035659 |
1 |
0.075
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.075
|
Human |
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.075
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.075
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.075
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.073
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.073
|
|
|
|
regulation of heart induction by regulation of canonical wnt signaling pathway
|
GO:0090081 |
1 |
0.073
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.072
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.072
|
Human |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.072
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.072
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.072
|
Human |
|
|
cd8 positive alpha beta t cell differentiation involved in immune response
|
GO:0002302 |
1 |
0.072
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.070
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.068
|
|
|
|
metanephros development
|
GO:0001656 |
16 |
0.068
|
Human |
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.068
|
Human |
|
|
response to hormone
|
GO:0009725 |
175 |
0.068
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.068
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
11 |
0.068
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.067
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.067
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.067
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.067
|
Human |
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.067
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.067
|
Human |
|
|
positive regulation of dermatome development
|
GO:0061184 |
3 |
0.066
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.066
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.066
|
Human |
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.066
|
Human |
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.065
|
Human |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.065
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.065
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.064
|
Human |
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.064
|
Human |
|
|
cytokine production
|
GO:0001816 |
247 |
0.064
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.064
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.064
|
Human |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.063
|
|
|
|
menstruation
|
GO:0042703 |
1 |
0.063
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.063
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.062
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.062
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.062
|
Human |
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
2 |
0.062
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.061
|
Human |
|
|
bone mineralization
|
GO:0030282 |
34 |
0.061
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.060
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.060
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.060
|
|
|
|
pulmonary vein morphogenesis
|
GO:0060577 |
1 |
0.060
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.060
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.060
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.060
|
|
|
|
globus pallidus development
|
GO:0021759 |
1 |
0.060
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.059
|
Human |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.059
|
Human |
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.059
|
Human |
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
11 |
0.059
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.059
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
9 |
0.058
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.058
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.058
|
Human |
|
|
regulation of odontogenesis
|
GO:0042481 |
4 |
0.058
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.058
|
Human |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.058
|
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.057
|
Human |
|
|
nephron development
|
GO:0072006 |
30 |
0.057
|
Human |
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.057
|
Human |
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.057
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.057
|
Human |
|
|
epithelial cell proliferation involved in lung morphogenesis
|
GO:0060502 |
3 |
0.056
|
Human |
|
|
limbic system development
|
GO:0021761 |
3 |
0.056
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.056
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.056
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.056
|
|
|
|
positive regulation of urothelial cell proliferation
|
GO:0050677 |
1 |
0.056
|
Human |
|
|
nephron morphogenesis
|
GO:0072028 |
15 |
0.055
|
Human |
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.055
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.055
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.055
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.055
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.054
|
Human |
|
|
renal tubule morphogenesis
|
GO:0061333 |
14 |
0.054
|
Human |
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.054
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.054
|
|
|
|
forebrain dorsal ventral pattern formation
|
GO:0021798 |
1 |
0.054
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.054
|
Human |
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.054
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.054
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.054
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.053
|
Human |
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.053
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.053
|
|
|
|
cartilage development
|
GO:0051216 |
31 |
0.052
|
Human |
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.052
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.052
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.052
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.052
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.052
|
Human |
|
|
nephric duct development
|
GO:0072176 |
4 |
0.051
|
|
|
|
luteinizing hormone secretion
|
GO:0032275 |
1 |
0.051
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.051
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.051
|
Human |
|
|
reproductive process
|
GO:0022414 |
106 |
0.051
|
Human |
|
|
optic nerve development
|
GO:0021554 |
2 |
0.051
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.051
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.050
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.050
|
Human |
|
|
neurological system process
|
GO:0050877 |
163 |
0.050
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.050
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.050
|
Human |
|
|
mesonephric tubule development
|
GO:0072164 |
14 |
0.050
|
Human |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.050
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.050
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
1 |
0.049
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.049
|
|
|
|
bmp signaling pathway involved in heart development
|
GO:0061312 |
3 |
0.049
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.049
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.049
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.049
|
Human |
|
|
regulation of organ formation
|
GO:0003156 |
4 |
0.048
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.048
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.048
|
Human |
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.048
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.048
|
Human |
|
|
tissue migration
|
GO:0090130 |
119 |
0.048
|
Human |
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.048
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.047
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.047
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.047
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.047
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.047
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.047
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.046
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.046
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
51 |
0.046
|
Human |
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.046
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.046
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.046
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.046
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.045
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.045
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.045
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
3 |
0.044
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.044
|
Human |
|
|
memory
|
GO:0007613 |
3 |
0.044
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.044
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.044
|
Human |
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.044
|
Human |
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.044
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.042
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.042
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.042
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.042
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.042
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.042
|
|
|
|
activation of mapk activity
|
GO:0000187 |
45 |
0.042
|
Human |
|
|
circulatory system process
|
GO:0003013 |
113 |
0.042
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.042
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.042
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.042
|
|
|
|
positive regulation of cell fate specification
|
GO:0042660 |
2 |
0.042
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.042
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.041
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.041
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.041
|
Human |
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.041
|
Human |
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.041
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.041
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.041
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.041
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.041
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.041
|
Human |
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.041
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.041
|
|
|
|
growth
|
GO:0040007 |
202 |
0.041
|
Human |
|
|
epithelium migration
|
GO:0090132 |
119 |
0.041
|
Human |
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.041
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.040
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.040
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.040
|
Human |
|
|
kidney morphogenesis
|
GO:0060993 |
19 |
0.040
|
Human |
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.040
|
Human |
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.040
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.040
|
Human |
|
|
protein maturation
|
GO:0051604 |
233 |
0.040
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.040
|
|
|
|
mesonephros development
|
GO:0001823 |
17 |
0.040
|
Human |
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.039
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.039
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.039
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.039
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.039
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.039
|
|
|
|
tongue development
|
GO:0043586 |
1 |
0.039
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.039
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.038
|
|
|
|
bone development
|
GO:0060348 |
26 |
0.038
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.038
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.038
|
Human |
|
|
dna replication
|
GO:0006260 |
116 |
0.037
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.037
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.037
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.037
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.037
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.037
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.037
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.037
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.037
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.037
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
13 |
0.036
|
|
|
|
mating
|
GO:0007618 |
1 |
0.036
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.036
|
|
|
|
soft palate development
|
GO:0060023 |
3 |
0.036
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.036
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.036
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.036
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.036
|
Human |
|
|
angiogenesis
|
GO:0001525 |
147 |
0.036
|
Human |
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.036
|
Human |
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.036
|
Human |
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.036
|
Human |
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.036
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.036
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.035
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.035
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.035
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
20 |
0.035
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.035
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.035
|
|
|
|
branch elongation involved in ureteric bud branching
|
GO:0060681 |
2 |
0.035
|
Human |
|
|
protein processing
|
GO:0016485 |
226 |
0.035
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.035
|
Human |
|
|
forebrain neuron development
|
GO:0021884 |
2 |
0.035
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.035
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.035
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.035
|
Human |
|
|
response to drug
|
GO:0042493 |
81 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.035
|
Human |
|
|
sex determination
|
GO:0007530 |
3 |
0.035
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.035
|
Human |
|
|
lung alveolus development
|
GO:0048286 |
4 |
0.035
|
Human |
|
|
lung associated mesenchyme development
|
GO:0060484 |
1 |
0.035
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.035
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
4 |
0.034
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.034
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.034
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.034
|
Human |
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.034
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.034
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.033
|
Human |
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.033
|
Human |
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
4 |
0.033
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.033
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.033
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.033
|
|
